Prostate-specific membrane antigen expression as a predictor of prostate cancer progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prostate-specific membrane antigen expression as a predictor of prostate cancer progression

Published:2007-05 Issue:5 Volume:38 Page:696-701
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Perner Sven,Hofer Matthias D.,Kim Robert,Shah Rajal B.,Li Haojie,Möller Peter,Hautmann Richard E.,Gschwend Juergen E.,Kuefer Rainer,Rubin Mark A.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference29 articles.

1. Radical prostatectomy versus watchful waiting in early prostate cancer;Bill-Axelson;N Engl J Med,2005

2. Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment;De Marzo;J Cell Biochem,2004

3. Isolation and characterization of monoclonal antibodies specific for the extracellular domain of prostate specific membrane antigen;Murphy;J Urol,1998

4. Expression of the prostate-specific membrane antigen;Israeli;Cancer Res,1994

5. Comparison of anti–prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma;Chang;Urology,2001

Cited by 383 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of the prostate cancer and its metastases in the [68Ga]Ga-PSMA PET/CT images: deep learning method vs. conventional PET/CT processing;Nuclear Medicine Communications;2024-09-03

2. An Analysis of the Diagnostic Performance of Tc-99m PSMA SSPECT/CT in Biochemically Recurrent Prostate Cancer Compared with Ga-68 PSMA PET/CT: A Single-center, Prospective Study;Indian Journal of Nuclear Medicine;2024-05

3. Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranostics;Analytical Sciences;2024-04-02

4. Determination of Critical Organ Doses with 177Lu Prostate-specific Membrane Antigen Dosimetry in Metastatic Prostate Cancer Treatment;Journal of Medical Physics;2024-04

5. Chimeric Antigen Receptor-Modified T Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer: Promise and Potential;Cancers;2024-03-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3